Invitation to Observe Medical ASA second half and full year 2023 presentation and Q&A
Oslo, March 6, 2024 - Observe Medical ("the Company" or "Observe Medical") will release its results for the second half and full year 2023 on Wednesday, 13 March 2024. The presentation will be published on NewsWeb and the Company's website at 07:00 CET on the same day.
The Company will host a presentation and Q&A session at 08:30 CET on the same day. Personal attendance is welcomed at Olav Vs gate 5, 0161 Oslo.
The session will also be streamed via webcast. To register and follow the presentation online, please copy and paste the following link into your browser, click attend and register your e-mail:
https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20240313_1
After the live event, the presentation and recording will be made available under the Investor Relations section on the Company's website,
https://observemedical.com/investor-relations/
For further information, please contact:
Jørgen Mann, Interim CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, Finance Manager Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care, in combination with targeted M&A.
The Company is headquartered in Oslo, Norway, with additional offices in Narvik, Norway and Gothenburg, Sweden, and subsidiaries in Finland and the US. In addition, Observe Medical has a direct sale organization in the Nordics and a distributor network internationally.
Further information is available at www.observemedical.com.
Tags: